Kidney Cancer Treatment Options: Surgery, Ablation, Systemic Therapy, and Surveillance
Management of kidney cancer is tailored to tumor stage and patient factors:
- Surgery: Radical nephrectomy (entire kidney) or partial/nephron-sparing nephrectomy (tumor only) for T1–T2 tumors. Laparoscopic and robotic approaches are standard.
- Ablation: Radiofrequency ablation (RFA), cryoablation, or microwave ablation for small tumors in patients who are not surgical candidates.
- Active surveillance: For small (<3 cm), low-grade tumors in elderly or comorbid patients—serial imaging monitors growth.
- Systemic therapy (advanced/metastatic disease):
- VEGF tyrosine kinase inhibitors: sunitinib, pazopanib, cabozantinib, lenvatinib.
- mTOR inhibitors: everolimus, temsirolimus.
- Immunotherapy: nivolumab, pembrolizumab, ipilimumab/nivolumab combination.
- Radiation therapy: Primarily palliative for bone or brain metastases; stereotactic body radiation therapy (SBRT) for oligometastatic disease.
A multidisciplinary tumor board optimizes treatment sequencing. Clinical trials provide access to novel agents.
Kidney Disease - Related Articles
- Kidney-Friendly Diet: Nutrition & Meal Planning for Kidney Health
- Kidney Tubules: Segmental Structure, Transport Functions, and Clinical Relevance
- Prevent Kidney Stones: Dietary Strategies & What to Avoid
- Bladder Infections and Kidney Complications: What You Need to Know
- Ureteral Anatomy: Where the Ureters Exit the Kidneys
- Kidney Disease Symptoms: Early Warning Signs to Watch For
- Kidney Failure Diet: Essential Tips & Nutrition for Renal Health
